Answers are grounded in this paper and cite their sources.
BACKGROUND: MRI-guided radiotherapy (MRIgRT) on a 1.5 T MR-Linac is constrained by a 22 cm maximum field length, limiting long continuous planning target volumes (PTVs). A dual-isocenter field-junction technique has been previously validated in a phantom study. This work presents its first clinical application in hypofractionated prostate radiotherapy. MATERIALS AND METHODS: A 79-year-old prostate cancer patient had six contiguous target volumes (PTV, CTV4000, PTVpubis, PGTVpubis, PTVp and PGTVnd), treated over 5 fractions with prescribed doses to the respective target volumes. PTVp was divided into PTVpup and PTVpdn, with a field overlap region between them. Two composite volumes were created: inferior volume (PTV, CTV4000, PTVpubis, PGTVpubis, PTVpdn) and superior volume (PTVpup, PGTVnd), each with its own isocenter. The inferior volume followed the adapt-to-shape (ATS) workflow. During its delivery, the superior volume was first optimized offline on daily MR images using dose feathering approach based on the inferior dose distribution. The optimized plan was then transferred for online adapt-to-position (ATP) adaptation. The inferior and superior volumes were combined offline for dose summation. The ArcCHECK phantom and ArcherQA Monte Carlo method were used for dose verification. Patient-reported outcomes, including FACT-P questionnaires, were collected during the 3-month follow-up. RESULTS: Treatment was delivered over 5 alternate-day fractions. ArcCHECK phantom gamma passing rates, using 3%/2 mm with a 10% threshold, were 96.7%, 97.1%, and 96.0% for the inferior, superior and composite reference plans, respectively. Daily ArcherQA showed consistently high passing rates across five fractions: 97.08%-98.43% for the inferior and 98.12%-98.74% for the superior volumes. CTV4000, PTV, PTVpubis and PGTVpub all met prescribed doses. PGTVnd and PTVp had intermittent underdose relative to initial prescriptions, but all fractions met second prescription limits. Organ at risks (OARs) constraints, especially for rectum and bladder, remained within tolerance across all fractions. Total treatment time decreased from 112 min in the first fraction to 80 min in the fifth fraction. FACT-P score declined from 69.17 at baseline to 55.5 at end-of-RT, partially recovering to 57.5 at 2.5 months. No urological or gastrointestinal toxicity was reported during follow-up. CONCLUSION: The proposed two-isocenter field junction technique is clinically feasible for MRIgRT of long continuous prostate cancer PTVs. It provides a practical solution for treating long PTVs on a 1.5 T MR-Linac.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: